We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+12.81%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$225M
AUM Growth
-$5.82M
Cap. Flow
-$29.2M
Cap. Flow %
-12.97%
Top 10 Hldgs %
45.19%
Holding
92
New
27
Increased
21
Reduced
24
Closed
19

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$5.69M
2
WMGI
Wright Medical Group Inc
WMGI
+$5.36M
3
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$5.15M
4
BMY icon
Bristol-Myers Squibb
BMY
+$4.63M
5
RCM
R1 RCM Inc. Common Stock
RCM
+$4.26M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$11.9M
2
ABT icon
Abbott
ABT
+$11.6M
3
JNJ icon
Johnson & Johnson
JNJ
+$7.46M
4
UHS icon
Universal Health Services
UHS
+$7.16M
5
AGN
Allergan plc
AGN
+$6.71M

Sector Composition

Rank Sector Weight
1 Healthcare 92.74%
2 Industrials 2.11%
3 Financials 2.08%
4 Technology 0.89%
5 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
76
Heron Therapeutics
HRTX
$98.9M
– –
-8,824
Closed -$343K
IQV icon
77
IQVIA
IQV
$37.8B
– –
-32,945
Closed -$3.29M
LH icon
78
Labcorp
LH
$24.8B
– –
-1,454
Closed -$224K
NKTR icon
79
Nektar Therapeutics
NKTR
$2.45B
– –
-527
Closed -$386K
REGN icon
80
Regeneron Pharmaceuticals
REGN
$77.9B
– –
-5,300
Closed -$1.83M
SBRA icon
81
Sabra Healthcare REIT
SBRA
$5.04B
– –
-90,922
Closed -$1.98M
TMO icon
82
Thermo Fisher Scientific
TMO
$209B
– –
-3,407
Closed -$706K
UHS icon
83
Universal Health Services
UHS
$9.96B
– –
-64,241
Closed -$7.16M
SYNH
84
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-39,198
Closed -$1.84M
BLCM
85
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-7,180
Closed -$530K
CLVS
86
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-30,500
Closed -$1.39M
PRAH
87
DELISTED
PRA Health Sciences, Inc.
PRAH
– –
-15,068
Closed -$1.41M
MNK
88
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-48,725
Closed -$909K
PTLA
89
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-20,803
Closed -$786K
ZGNX
90
DELISTED
Zogenix, Inc.
ZGNX
– –
-6,473
Closed -$286K
1 2 3
4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Endurant Capital Management held 92 positions worth $225M, down 2.5% from $231M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Endurant Capital Management withdrew a net $29.2M in Q3 2018, closing 19 positions and reducing 24 holdings. Its most notable exit was Universal Health Services, an estimated $7.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 94% a quarter earlier, followed by Industrials and Financials.

Against the trend, Endurant Capital Management opened a new position in Sanofi worth $5.95M.

  • Endurant Capital Management's largest Q3 2018 buy was Sanofi: 133,245 shares worth $5.95M.
  • Endurant Capital Management added most to Wright Medical Group Inc in Q3 2018, an estimated $5.36M increase.
  • Endurant Capital Management's biggest Q3 2018 reduction was Merck, cutting an estimated $11.9M.
  • Endurant Capital Management fully exited Universal Health Services in Q3 2018, selling an estimated $7.16M.
  • Endurant Capital Management's ten largest holdings make up 45% of its $225M portfolio in Q3 2018.
  • Endurant Capital Management opened 27 new positions and closed 19 in Q3 2018.
  • Endurant Capital Management's portfolio value fell 2.5% quarter-over-quarter to $225M.

Based on Endurant Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.